Oncologists Optimistic About Prospects for CAR T-Cell Therapy

Share this post

Ninety percent of the respondents to a survey said that if approved by the FDA, CAR T-cell therapies would be important or very important in hematologic cancers.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply